MSF Urges Pfizer, GlaxoSmithKline To Cut Pneumococcal Vaccine Prices For Children In Developing Countries
The Guardian: Pharmaceutical companies told to slash price of pneumococcal disease vaccine
“Two giant pharmaceutical companies should lower the price of a new vaccine against pneumococcal disease that is needed by children in developing countries, but is unaffordable for some of their governments, say the volunteer doctors of Médecins Sans Frontières (MSF)…” (Boseley, 1/20).
Reuters: MSF slams expensive vaccines, urges GSK and Pfizer to cut prices
“…In a report on vaccine prices ahead of an international donor conference in Berlin at the end of January, MSF slammed Big Pharma companies and said the cost of vaccinating a child in the world’s poorest countries was now 68 times higher than in 2001…” (Kelland, 1/20).
The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.